supp.fit

Fish Oil and Docosahexaenoic Acid: study protocols

9 study groups took Fish Oil together with Docosahexaenoic Acid. These are the doses the studies gave. They are not a recommendation.

Fish Oil: what the research found →

Dose per serving from research: Fish Oil

9 study groups in 7 studies say how much Fish Oil participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 2.5 g to 5 g, 44% of 9 study groups.

Daily doseStudy groups
250 mg or less
1
250 mg to 500 mg
0
500 mg to 1 g
2
1 g to 2.5 g
1
2.5 g to 5 g
4
5 g to 10 g
1

Dose per serving from research: Docosahexaenoic Acid

9 study groups in 7 studies say how much Docosahexaenoic Acid participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mg to 1 g, 33% of 9 study groups.

Daily doseStudy groups
100 mg to 250 mg
1
250 mg to 500 mg
1
500 mg to 1 g
3
1 g to 2.5 g
2
2.5 g to 5 g
2

Commonly used together

8 of 9 study groups took Fish Oil and Docosahexaenoic Acid with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Omega-3 Fatty Acids
4

9 study groups

Study
Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial
2012 · n-3 LCPUFA group · Pregnant women from Adelaide whose unborn baby had a mother, father, or sibling with a history of medically diagnosed allergic disease
1.5 g800 mg—368
Effects of Varied Omega-3 Fatty Acid Supplementation on Postpartum Mental Health and the Association between Prenatal Erythrocyte Omega-3 Fatty Acid Levels and Postpartum Mental Health
2023 · fish oil group · Healthy primiparous pregnant women aged 19–45 years
5.2 g400 mg12 weeks124
Fish Oil And/Or Probiotics Intervention in Overweight/Obese Pregnant Women and Overweight Risk in 24-Month-Old Children
2023 · Fish oil + placebo · Pregnant women with overweight or obesity, enrolled before 18 gestational weeks; no chronic diseases stated
4.8 g3.8 g—82
Fish Oil And/Or Probiotics Intervention in Overweight/Obese Pregnant Women and Overweight Risk in 24-Month-Old Children
2023 · Probiotics + fish oil · Pregnant women with overweight or obesity, enrolled before 18 gestational weeks; no chronic diseases stated
4.8 g3.8 g—82
Prevention of Potential Adverse Metabolic Effects of a Supplementation with Omega-3 Fatty Acids Using a Genetic Score Approach
2020 · n-3 PUFA supplementation · Adults; age, sex, and health condition not specified
5 g1.1 g6 weeks210
Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
2017 · Lovaza · Adults aged 36–80 with stable coronary artery disease and overweight/obesity or metabolic-syndrome features; included participants with and without type 2 diabetes
3.36 g1.5 g1 year147
Synbiotic Bacillus megaterium DSM 32963 and n-3 PUFA Salt Composition Elevates Pro-Resolving Lipid Mediator Levels in Healthy Subjects: A Randomized Controlled Study
2024 · Fish oil group · Healthy men and women aged 30–75 years, selected as at-risk individuals with omega-3 index ≤6.5% and elevated AGEs and/or hsCRP
180 mg120 mg4 weeks—
Red Blood Cell Omega-3 Fatty Acid Composition and Psychotropic Drug Use in Older Adults: Results from the MAPT Study
2019 · PUFA supplementation alone · Adults aged 70 years or older with a memory complaint, an instrumental activity limitation, or slow walking speed
800 mg800 mg3 years401
Red Blood Cell Omega-3 Fatty Acid Composition and Psychotropic Drug Use in Older Adults: Results from the MAPT Study
2019 · PUFA supplementation + multidomain intervention · Adults aged 70 years or older with a memory complaint, an instrumental activity limitation, or slow walking speed
800 mg800 mg3 years399
Fish Oil and Docosahexaenoic Acid: study protocols | supp.fit